EPM2AIP1 anticorps
Aperçu rapide pour EPM2AIP1 anticorps (ABIN2720297)
Antigène
Voir toutes EPM2AIP1 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
Clone
-
-
Attributs du produit
- Homo sapiens EPM2A (laforin) interacting protein 1 (EPM2AIP1)
-
Purification
- Purified from mouse ascites fluids by affinity chromatography
-
Immunogène
- Full length human recombinant protein of human EPM2AIP1(NP_055620) produced in HEK293T cell.
-
Isotype
- IgG2b
-
-
-
-
Indications d'application
- WB 1:2000, IHC 1:150, FLOW 1:100,
-
Commentaires
-
The concentration of the product may vary between diferrent lots.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 0.5-1.0 mg/mL
-
Buffer
- PBS (PH 7.3) containing 1 % BSA, 50 % glycerol and 0.02 % sodium azide.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C
-
-
- EPM2AIP1 (EPM2A (Laforin) Interacting Protein 1 (EPM2AIP1))
-
Autre désignation
- EPM2AIP1
-
Sujet
- The EPM2A gene, which encodes laforin, is mutated in an autosomal recessive form of adolescent progressive myoclonus epilepsy. The protein encoded by this gene binds to laforin, but its function is not known. This gene is intronless. COMPLETENESS: complete on the 3' end.
-
Poids moléculaire
- 70.2 kDa
-
ID gène
- 9852
-
NCBI Accession
- NM_014805
-
HGNC
- 9852
Antigène
-